CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Dequalinium

地喹氯铵 杂质对照品Dequalinium Impurities

EP17 个杂质条目17 impurity entries

本页汇总 地喹氯铵 的 17 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 17 impurity reference standards of Dequalinium with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 地喹氯铵(Dequalinium)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA nuclear magnetic resonance method for the determination of the purity of commercial dequalinium chloride
    Arzneimittel-Forschung · 1995 · Boschetti C et al.  ·  PMID 8929243
  2. 分析方法Analytical MethodsNew method for the quantification of dequalinium cations in pharmaceutical samples by absorption and fluorescence diode array thin-layer chromatography
    Journal of chromatography. A · 2009 · Hiegel K, Spangenberg B  ·  PMID 19446824  ·  DOI
  3. 分析方法Analytical MethodsDetermination of the quaternary ammonium compounds dequalinium and cetylpyridinium chlorides in candy-based lozenges by high-performance liquid chromatography
    The Analyst · 1997 · Taylor RB et al.  ·  PMID 9374026  ·  DOI
  4. 分析方法Analytical MethodsFlow injection spectrofluorimetric study of the supramolecular interaction between beta-cyclodextrin and dequalinium chloride and its analytical application
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2005 · Tang B et al.  ·  PMID 15911412  ·  DOI
  5. 分析方法Analytical MethodsDetermination for micro amounts of nucleic acids by a resonance light scattering technique with dequalinium chloride
    Talanta · 2001 · Li ZP et al.  ·  PMID 18968413  ·  DOI

地喹氯铵 —— 原料药与杂质对照品Dequalinium — drug substance & impurities

共 17 个条目(含原料药本体)17 items incl. the drug substance
Dequalinium Chloride structure
EP原料药 APIAPI
地喹氯铵Dequalinium Chloride
Dequalinium Chloride
CAS No.522-51-0
Chemical FormulaC30H40N42+·2Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 1 (Dequalinium Chloride EP Impurity A) structure
EPA
地喹氯铵杂质1 (地喹氯铵氯化物EP杂质A)Dequalinium Impurity 1 (Dequalinium Chloride EP Impurity A)
Dequalinium Impurity 1 (Dequalinium Chloride EP Impurity A)
CAS No.6628-04-2
Chemical FormulaC10H10N2
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 2 (Dequalinium Chloride EP Impurity B Chloride) structure
EPB
地喹氯铵杂质2 (地喹氯铵氯化物EP杂质B 氯化物)Dequalinium Impurity 2 (Dequalinium Chloride EP Impurity B Chloride)
Dequalinium Impurity 2 (Dequalinium Chloride EP Impurity B Chloride)
CAS No.171980-52-2
Chemical FormulaC30H39ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 2 Monomer (Dequalinium Chloride EP Impurity B) structure
EPB
地喹氯铵杂质2 单体 (地喹氯铵氯化物EP杂质B)Dequalinium Impurity 2 Monomer (Dequalinium Chloride EP Impurity B)
Dequalinium Impurity 2 Monomer (Dequalinium Chloride EP Impurity B)
CAS No.747387-02-6
Chemical FormulaC30H39N4+
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 3(Dequalinium EP Impurity C) structure
EPC
地喹氯铵杂质3(地喹氯铵EP杂质C)Dequalinium Impurity 3(Dequalinium EP Impurity C)
Dequalinium Impurity 3(Dequalinium EP Impurity C)
CAS No.171980-50-0
Chemical FormulaC50H69Cl3N6
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 3 Monomer (Dequalinium EP Impurity C Monomer) structure
EPC
地喹氯铵杂质3 单体 (地喹氯铵 EP杂质C 单体)Dequalinium Impurity 3 Monomer (Dequalinium EP Impurity C Monomer)
Dequalinium Impurity 3 Monomer (Dequalinium EP Impurity C Monomer)
CAS No.782426-88-4
Chemical FormulaC50H69N63+
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 5 structure
5
地喹氯铵杂质5Dequalinium Impurity 5
Dequalinium Impurity 5
CAS No.19056-26-9
Chemical FormulaC30H38N4
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 7 structure
7
地喹氯铵杂质7Dequalinium Impurity 7
Dequalinium Impurity 7
CAS No.514-73-8
Chemical FormulaC23H23N2S2+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 8 structure
8
地喹氯铵杂质8Dequalinium Impurity 8
Dequalinium Impurity 8
CAS No.16355-92-3
Chemical FormulaC10H20I2
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 9 structure
9
地喹氯铵杂质9Dequalinium Impurity 9
Dequalinium Impurity 9
CAS No.2019-42-3
Chemical FormulaC30H40I2N4
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 12 structure
12
地喹氯铵杂质12Dequalinium Impurity 12
Dequalinium Impurity 12
CAS No.874532-58-8
Chemical FormulaC18H18N2O
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 13 structure
13
地喹氯铵杂质13Dequalinium Impurity 13
Dequalinium Impurity 13
CAS No.27063-27-0
Chemical FormulaC10H10N2
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 18 structure
18
地喹氯铵杂质18Dequalinium Impurity 18
Dequalinium Impurity 18
CAS No.24772-63-2
Chemical FormulaC8H16I2
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 19 structure
19
地喹氯铵杂质19Dequalinium Impurity 19
Dequalinium Impurity 19
CAS No.64334-96-9
Chemical FormulaC10H10N2
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 20 structure
20
地喹氯铵杂质20Dequalinium Impurity 20
Dequalinium Impurity 20
CAS No.15821-13-3
Chemical FormulaC11H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 22 structure
22
地喹氯铵杂质22Dequalinium Impurity 22
Dequalinium Impurity 22
CAS No.5632-13-3
Chemical FormulaC10H10N2
Purity>95%询价On request
10mg25mg50mg100mg
Dequalinium Impurity 24 structure
24
地喹氯铵杂质24Dequalinium Impurity 24
Dequalinium Impurity 24
CAS No.4101-68-2
Chemical FormulaC10H20Br2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

地喹氯铵 —— 研究文献与合成路线Dequalinium — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 地喹氯铵 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Dequalinium. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A New Reverse Phase High-Performance Liquid Chromatography (RP- HPLC) Method for Determination of Kinetin Riboside (plant hormone) in Dequalinium Chloride Based Self-Assembled Vesicles: Development, Validation, and Force Degradation Study
    Agnihotri TG, Badgujar D, Sharma N, et al. · 2022
  2. New method for the quantification of dequalinium cations in pharmaceutical samples by absorption and fluorescence diode array thin-layer chromatography
    Hiegel K, Spangenberg B · Journal of chromatography. A · 2009 · 被引 4cited 4

合成路线文献Synthetic-route papers

  1. Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers
    Campos Rosa J, Galanakis D, Ganellin CR, et al. · Journal of medicinal chemistry · 1996
  2. Synthesis and structure-activity relationships of dequalinium analogues as K+ channel blockers. Investigations on the role of the charged heterocycle
    Galanakis D, Davis CA, Del Rey Herrero B, et al. · Journal of medicinal chemistry · 1995
  3. Synthesis and pharmacological testing of dequalinium analogues as blockers of the apamin-sensitive Ca(2+)-activated K+ channel: variation of the length of the alkylene chain
    Galanakis D, Ganellin CR, Malik S, et al. · Journal of medicinal chemistry · 1996

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

地喹氯铵 杂质谱研究要点Dequalinium — impurity profiling notes

下面这些是拿到 地喹氯铵 的 17 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 17 impurity entries for Dequalinium, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances